Hims & Hers Stock Skyrockets as Novo Nordisk Weight-Loss Drug Deal Changes Industry Dynamics | MarketWire

Hims & Hers shares soar 38% after Novo Nordisk agrees to distribute weight-loss drugs like Ozempic and Wegovy on its platform.